Back to Search Start Over

215P Concurrent sorafenib therapy extends the interval to subsequent TACE for patients with unresectable hepatocellular carcinoma

Authors :
Huiying Zeng
Xuesong Yao
Dong Yan
H Li
Dezhong Liu
Source :
Annals of Oncology. 26:ix42
Publication Year :
2015
Publisher :
Elsevier BV, 2015.

Subjects

Subjects :
Sorafenib
Oncology
medicine.medical_specialty
business.industry
Hepatocellular carcinoma
Internal medicine
Medicine
Interval (graph theory)
Hematology
business
medicine.disease
medicine.drug

Details

ISSN :
09237534
Volume :
26
Database :
OpenAIRE
Journal :
Annals of Oncology
Accession number :
edsair.doi...........f860c3d2ea0c14e285e2407cd9b391df
Full Text :
https://doi.org/10.1093/annonc/mdv523.76
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details